Recent Updates
Recently added Catalysts
IMRN Positive Sentiment Score: 75/100

Immuron CEO, Steven Lydeamore to present at Bioshares

Monday, July 24, 2023 1 min read
Key Takeaway: Steven Lydeamore, the CEO of Immuron Limited, is set to present at the 17th Bioshares Biotech Summit in Hobart, Australia on July 24, 2023. The event emphasizes Immuron's efforts in the biopharmaceutical sector, focusing on the development of orally delivered targeted polyclonal antibodies. A copy of the presentation slide deck has been made available on the company's website, enhancing transparency for stakeholders. The participation in this summit signifies an opportunity for Immuron to engage with the biotech community and showcase its advancements.

Market Sentiment Analysis

POSITIVE FACTORS

  • CEO Steven Lydeamore will present at a significant biotech event.
  • The presentation highlights the company's focus on developing innovative treatments.
  • Immuron is gaining exposure within the biopharma industry.

Full Press Release Details

MELBOURNE, Australia, July 24, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore will be presenting at the 17th Bioshares Biotech Summit in Hobart, Australia on July 24th.
A copy of the presentation slide deck is available on the Company’s website.
https://www.immuron.com.au/corporate-presentations/
This release has been authorised by the directors of Immuron Limited.
Chief Executive Officer
Ph: +61 (0)3 9824 5254
Immuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercialising orally delivered targeted polyclonal antibodies for the treatment of infectious diseases.
For more information visit: http://www.immuron.com

Tags

Frequently Asked Questions

When is Steven Lydeamore presenting?

Steven Lydeamore will present on July 24, 2023.

Where is the Bioshares Biotech Summit held?

The summit is held in Hobart, Australia.

What type of company is Immuron Limited?

Immuron Limited is a biopharmaceutical company based in Australia.

What does Immuron focus on developing?

Immuron focuses on orally delivered targeted polyclonal antibodies.

How can I access the presentation slide deck?

The slide deck is available on Immuron's website.

Tags: IMRN Viatris Investor Conferences Healthcare Immuron Steven Lydeamore Bioshares Biotech Summit ASX: IMC NASDAQ: IMRN
Last updated: Jul 24, 2023